Akari Therapeutcis' (NASDAQ: AKTX) treatment of paroxysmal nocturnal hemoglobinuria received FDA orphan drug designation. The generic name is ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE